Cargando…

Evaluation of pre-analytical conditions and comparison of the performance of several digital PCR assays for the detection of major EGFR mutations in circulating DNA from non-small cell lung cancers: the CIRCAN_0 study

Non invasive somatic detection assays are suitable for repetitive tumor characterization or for detecting the appearance of somatic resistance during lung cancer. Molecular diagnosis based on circulating free DNA (cfDNA) offers the opportunity to track the genomic evolution of the tumor, and was cho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garcia, Jessica, Dusserre, Eric, Cheynet, Valérie, Bringuier, Pierre Paul, Brengle-Pesce, Karen, Wozny, Anne-Sophie, Rodriguez-Lafrasse, Claire, Freyer, Gilles, Brevet, Marie, Payen, Léa, Couraud, Sébastien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675687/ https://www.ncbi.nlm.nih.gov/pubmed/29152135 http://dx.doi.org/10.18632/oncotarget.21256

Ejemplares similares

Cross-platform comparison for the detection of RAS mutations in cfDNA (ddPCR Biorad detection assay, BEAMing assay, and NGS strategy)
por: Garcia, Jessica, et al.
Publicado: (2018)

Profiling of circulating tumor DNA in plasma of non‐small cell lung cancer patients, monitoring of epidermal growth factor receptor p.T790M mutated allelic fraction using beads, emulsion, amplification, and magnetics companion assay and evaluation in future application in mimicking circulating tumor cells
por: Garcia, Jessica, et al.
Publicado: (2019)

Comparison and Validation of Rapid Molecular Testing Methods for Theranostic Epidermal Growth Factor Receptor Alterations in Lung Cancer: Idylla versus Digital Droplet PCR
por: Léonce, Camille, et al.
Publicado: (2023)

Paired Comparison of Routine Molecular Screening of Patient Samples with Advanced Non-Small Cell Lung Cancer in Circulating Cell-Free DNA Using Three Targeted Assays
por: Barthelemy, David, et al.
Publicado: (2023)

Circulating H3K27 Methylated Nucleosome Plasma Concentration: Synergistic Information with Circulating Tumor DNA Molecular Profiling
por: Grolleau, Emmanuel, et al.
Publicado: (2023)

Routine Molecular Screening of Patients with Advanced Non-SmallCell Lung Cancer in Circulating Cell-Free DNA at Diagnosis and During Progression Using OncoBEAM(TM)EGFR V2 and NGS Technologies
por: Garcia, Jessica, et al.
Publicado: (2021)

Circulating Tumor Cell Detection during Neoadjuvant Chemotherapy to Predict Early Response in Locally Advanced Oropharyngeal Cancers: A Prospective Pilot Study
por: Gauthier, Arnaud, et al.
Publicado: (2022)

Uncommon EGFR mutations in lung adenocarcinoma: features and response to tyrosine kinase inhibitors
por: Brindel, Aurélien, et al.
Publicado: (2020)

Embryonated Chicken Tumor Xenografts Derived from Circulating Tumor Cells as a Relevant Model to Study Metastatic Dissemination: A Proof of Concept
por: Rousset, Xavier, et al.
Publicado: (2022)

The ‘stealth-bomber’ paradigm for deciphering the tumour response to carbon-ion irradiation
por: Wozny, Anne-Sophie, et al.
Publicado: (2023)

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
por: Pérot, Philippe, et al.
Publicado: (2013)

Sensitivity, specificity, and accuracy of a liquid biopsy approach utilizing molecular amplification pools
por: Garcia, Jessica, et al.
Publicado: (2021)

Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping
por: Kim, Hye-Ryoun, et al.
Publicado: (2013)

Performance Assessment of SARS-CoV-2 PCR Assays Developed by WHO Referral Laboratories
por: Etievant, Sibyle, et al.
Publicado: (2020)

EGFR Mutation Analysis of Circulating Tumor DNA Using an Improved PNA-LNA PCR Clamp Method
por: Watanabe, Kana, et al.
Publicado: (2016)

Diagnostic accuracy of droplet digital PCR for detection of EGFR T790M mutation in circulating tumor DNA
por: Zhang, Rui, et al.
Publicado: (2018)

Frequency of MET exon 14 skipping mutations in non-small cell lung cancer according to technical approach in routine diagnosis: results from a real-life cohort of 2,369 patients
por: Champagnac, Anne, et al.
Publicado: (2020)

Identification of the hASCT2-binding domain of the Env ERVWE1/syncytin-1 fusogenic glycoprotein
por: Cheynet, Valérie, et al.
Publicado: (2006)

Comparison of droplet digital PCR and conventional quantitative PCR for measuring EGFR gene mutation
por: ZHANG, BO, et al.
Publicado: (2015)

Multicenter Evaluation of Independent High-Throughput and RT-qPCR Technologies for the Development of Analytical Workflows for Circulating miRNA Analysis
por: Babayan, Anna, et al.
Publicado: (2020)

Crystal digital droplet PCR for detection and quantification of circulating EGFR sensitizing and resistance mutations in advanced non-small cell lung cancer
por: Jovelet, Cécile, et al.
Publicado: (2017)

Rapid detection of EGFR mutations in decalcified lung cancer bone metastasis
por: Boureille, Antoine, et al.
Publicado: (2020)

Detection of EGFR Activating and Resistance Mutations by Droplet Digital PCR in Sputum of EGFR-Mutated NSCLC Patients
por: Hackner, Klaus, et al.
Publicado: (2021)

Comparison of Nucleic Acid Extraction Methods for a Viral Metagenomics Analysis of Respiratory Viruses
por: Sabatier, Marina, et al.
Publicado: (2020)

Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer
por: Maillet, Denis, et al.
Publicado: (2021)

Radiation-induced bystander and abscopal effects: important lessons from preclinical models
por: Daguenet, Elisabeth, et al.
Publicado: (2020)

A Review of the Role of Hypoxia in Radioresistance in Cancer Therapy
por: Boulefour, Wafa, et al.
Publicado: (2021)

Analytical device miniaturization for the detection of circulating biomarkers
por: Natalia, Auginia, et al.
Publicado: (2023)

Impact of hypoxia on the double-strand break repair after photon and carbon ion irradiation of radioresistant HNSCC cells
por: Wozny, Anne-Sophie, et al.
Publicado: (2020)

Early responses of EGFR circulating tumor DNA to EGFR tyrosine kinase inhibitors in lung cancer treatment
por: Imamura, Fumio, et al.
Publicado: (2016)

Dynamic Evaluation of Circulating miRNA Profile in EGFR-Mutated NSCLC Patients Treated with EGFR-TKIs
por: Leonetti, Alessandro, et al.
Publicado: (2021)

Circulating Tumor DNA in Identifying Resistant Sub-Clones Post EGFR Blockade: Implications for EGFR Rechallenge
por: Chennamadhavuni, Adithya, et al.
Publicado: (2022)

Plasma hPG(80) (Circulating Progastrin) as a Novel Prognostic Biomarker for early-stage breast cancer in a breast cancer cohort
por: Prieur, Alexandre, et al.
Publicado: (2023)

Wolfgang Pauli et l'arrière-plan de la physique
por: Bringuier, Eric
Publicado: (2003)

Metagenomic Next-Generation Sequencing Reveals Individual Composition and Dynamics of Anelloviruses during Autologous Stem Cell Transplant Recipient Management
por: Bal, Antonin, et al.
Publicado: (2018)

Metagenomic Investigation of Torque Teno Mini Virus-SH in Hematological Patients
por: Bal, Antonin, et al.
Publicado: (2019)

EGFR C797S, EGFR T790M and EGFR sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCR
por: Madic, Jordan, et al.
Publicado: (2018)

Seroconversion in septic ICU patients presenting with COVID-19: necessary but not sufficient
por: Conti, Filippo, et al.
Publicado: (2021)

Estimation of cell-free circulating EGFR mutation concentration predicts outcomes in NSCLC patients treated with EGFR-TKIs
por: Zhu, Yan-juan, et al.
Publicado: (2017)

Detection of EGFR mutation in plasma using multiplex allele-specific PCR (MAS-PCR) and surface enhanced Raman spectroscopy
por: Li, Xiaozhou, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nnuqcgqd876bg60ra3kd0lnuuo